MARKET

NOVN

NOVN

Novan
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3444
-0.1057
-23.48%
After Hours: 0.3401 -0.0043 -1.25% 19:46 02/27 EST
OPEN
0.4200
PREV CLOSE
0.4501
HIGH
0.4501
LOW
0.3325
VOLUME
970.28K
TURNOVER
--
52 WEEK HIGH
3.720
52 WEEK LOW
0.3325
MARKET CAP
9.45M
P/E (TTM)
-0.3418
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NOVN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NOVN stock price target is 1.500 with a high estimate of 1.500 and a low estimate of 1.500.

EPS

NOVN News

More
  • Novan Announces Pricing of $5.5 Million Public Offering
  • GlobeNewswire · 2h ago
  • Novan Reports Offering Of Common Stock, No Terms Disclosed
  • Benzinga · 9h ago
  • Novan Announces Proposed Public Offering
  • GlobeNewswire · 10h ago
  • Novan files $150M shelf registration in wake of stock drop
  • American City Business Journals · 1d ago

Industry

Pharmaceuticals
-2.62%
Pharmaceuticals & Medical Research
-2.52%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About NOVN

Novan, Inc. is a clinical development-stage biotechnology company. The Company is focused on leveraging nitric oxide’s naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases. The Company has created a Nitricil technology platform enabling the development of new chemical entities (NCEs) with delivery of nitric oxide. The Company’s two key components of its nitric oxide platform are its Nitricil technology, which drives the creation of NCEs, and its formulation science, both of which it uses to tune its product candidates for specific indications. Novan’s Nitricil technology enables it to store large amounts of nitric oxide gas in a stable, solid form by chemically loading it on a macromolecule, or polymer. The nitric oxide platform has produced a portfolio that includes the various clinical stage dermatology product candidates: SB204, SB206, SB208 and SB414.
More

Webull offers kinds of Novan Inc stock information, including NASDAQ:NOVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NOVN stock news, and many more online research tools to help you make informed decisions.